Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.2K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.2K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.2K
Embryonic Stem Cells00:58

Embryonic Stem Cells

29.9K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
29.9K
Overview of Exosomes01:36

Overview of Exosomes

3.2K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.2K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.0K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methotrexate-induced hepatotoxicity-mechanism, clinical cases and treatment approaches.

Toxicological research·2026
Same author

Therapeutic exosomes in cancer: efficacy and safety perspectives.

RSC advances·2026
Same author

Cytotoxicity and potential cell death mechanisms of three new benzamidine derivatives in esophageal squamous cell carcinoma cells using in vitro and in silico approaches.

Cytotechnology·2026
Same author

Pharmacological evaluation of Lonafarnib in reversing neurobehavioral, neurochemical and metabolic deficit in mouse models of chronic unpredictable mild stress (CUMS).

Metabolic brain disease·2026
Same author

SmartLipids in Drug Delivery: Redefining the Third Generation of Lipid Nanocarriers for Clinical and Industrial Translation.

International journal of nanomedicine·2026
Same author

Biopolymer Hydrogel-Based Nanocomposites Functionalized with Natural Products for Wound Dressings: Translational Advances in Drug Design, Development, and Therapeutic Wound Care.

Drug design, development and therapy·2026

Related Experiment Video

Updated: Nov 15, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.3K

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Regenerative Potential and Challenges.

Shivkanya Fuloria1, Vetriselvan Subramaniyan2, Rajiv Dahiya3

  • 1Faculty of Pharmacy, AIMST University, Kedah 08100, Malaysia.

Biology
|March 6, 2021
PubMed
Summary

Mesenchymal stem cell extracellular vesicles (MSCEVs) show regenerative promise for tissue repair. This review highlights challenges in translating MSCEV preclinical research into clinical applications, focusing on production, characterization, and safety.

Keywords:
cell injuryextracellular vesiclesregenerative potentialstem cellstherapeutics

More Related Videos

Setting a Successful Sorting for Extracellular Vesicle Isolation
08:37

Setting a Successful Sorting for Extracellular Vesicle Isolation

Published on: October 11, 2024

1.4K
A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
09:10

A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells

Published on: June 23, 2022

1.7K

Related Experiment Videos

Last Updated: Nov 15, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.3K
Setting a Successful Sorting for Extracellular Vesicle Isolation
08:37

Setting a Successful Sorting for Extracellular Vesicle Isolation

Published on: October 11, 2024

1.4K
A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
09:10

A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells

Published on: June 23, 2022

1.7K

Area of Science:

  • Regenerative Medicine
  • Biotechnology
  • Cell Biology

Background:

  • Stem cells, particularly mesenchymal stem cells (MSCs), exert regenerative effects through secreted extracellular vesicles (EVs).
  • Mesenchymal stem cell extracellular vesicles (MSCEVs) demonstrate therapeutic potential in preclinical models for diverse pathological conditions.
  • Optimizing MSC culturing and bioengineering of EVs can enhance MSCEV therapeutic efficacy.

Purpose of the Study:

  • To review the regenerative potential of MSCEVs across various organs and tissues.
  • To identify and discuss critical challenges in translating preclinical MSCEV research to clinical settings.
  • To provide evidence supporting MSCEVs as a therapeutic platform for tissue restoration.

Main Methods:

  • Literature review of preclinical studies on MSCEVs.
  • Analysis of challenges in MSCEV production, characterization, and clinical translation.
  • Synthesis of evidence for MSCEV efficacy in liver, kidney, heart, nervous system, bone, muscle, and cartilage regeneration.

Main Results:

  • MSCEVs show promise in preclinical models for regenerating multiple tissue types.
  • Significant hurdles exist in clinical translation, including scalable production, standardization, pharmacokinetics, and safety profiling.
  • Current clinical trials have raised questions regarding MSCEV superiority and consistency.

Conclusions:

  • Addressing challenges in production, characterization, delivery, and safety is crucial for successful clinical translation of MSCEVs.
  • Further research and development are needed to overcome limitations and harness the full therapeutic potential of MSCEVs.
  • MSCEVs represent a promising cell-free therapeutic strategy for regenerative medicine, pending resolution of translational challenges.